CTRI/2021/01/030415
Not yet recruiting
Phase 3
Diagnostic utility of Fluorescence and Diffuse Reflectance Imaging in gastrointestinal luminal pathology
Dr Stanley Mathew0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Health Condition 1: C15-C26- Malignant neoplasms of digestive organs
- Sponsor
- Dr Stanley Mathew
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients above 18 years of age operated by the General Surgery Department of Kasturba Hospital, Manipal for gastrointestinal luminal malignancies during the study period
Exclusion Criteria
- •Age less than 18 years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of the benefit of fluorescence diagnostics using Metvix® and the Dyaderm system for the preoperational estimation of the lateral tumour spread in basal cell carcinomas. - FD-BZKEUCTR2007-004790-25-DEniversity of Leipzig
Active, not recruiting
Phase 1
Application of fluorescence diagnosis (FDAP) and photodynamic therapy (PDT) in psoriasis and premalignancies of the skin - FDAP and PDT of the skiEUCTR2006-003981-33-NLMC ST Radboud40
Not yet recruiting
Not Applicable
Fluorescence Imaging for the Evaluation of Disease Activity in IBD and Rheumatoid Arthritis using the fluorescent tracer OTL38 targeting the folate B receptor: a single-center pilot study.Crohn's diseasereumatoid arthritisulcerative colitis1001796910003816NL-OMON48394niversitair Medisch Centrum Groningen30
Recruiting
Phase 2
Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor BiomarkerBrain CancerNCT02691923David W. Roberts30
Recruiting
Phase 2
Validation of the Utility of Indocyanine Green for Fluorescence Imaging in Pediatric Gastrointestinal SurgeryJPRN-jRCT1031230519Takeda Masahiro60